Drug
Sulindac clinical trials
Also written Clinoril.
- studies test it
- 24
- open now
- 0
- in phase 3
- 4
- first study started
- 1996
How studies write it
Studies that test it under each name
Brand
Combined with it in one product
- DFMO
- 1
Studies by the year they started
24 studies that test it; most in 2006 (6)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1998 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 15
- Phase 3
- 4
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 21
National Cancer Institute (NCI) (6) · Cancer Prevention Pharmaceuticals, Inc. (3) · Massachusetts General Hospital (2) · SWOG Cancer Research Network (1) · Duke University (1) · University of Pittsburgh (1) · Stony Brook University (1) · Memorial Sloan Kettering Cancer Center (1)
Often tested with
Tested in the same studies.
Eflornithine (5) · Erlotinib (2) · Tamoxifen (1) · Oligofructose-Enriched Inulin (1) · Atorvastatin (1) · Epirubicin (1) · Docetaxel (1) · Bevacizumab (1)
Studies
Open first, then newest update. How each study uses Sulindac is read from its arms, and is right about nine times in ten.
Testing it · 24
- S0820, Adenoma and Second Primary Prevention TrialActive, not recruitingPhase 3SWOG Cancer Research NetworkNCT01349881Written as Eflornithine plus sulindac
- The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)Active, not recruitingPhase 2Duke UniversityNCT04207944Written as Sulindac 400 MG
- Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedPhase 1University of PittsburghNCT01515137Written as Erlotinib plus sulindac
- NSAID Effects on Clinical and Imaging Breast BiomarkersCompletedPhase 2Stony Brook UniversityNCT01761877Written as Sulindac
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)CompletedPhase 3Cancer Prevention Pharmaceuticals, Inc.NCT01483144Written as Sulindac 150 MG
- A Randomized Study of Sulindac in Oral Premalignant LesionsCompletedNot applicableMemorial Sloan Kettering Cancer CenterNCT00299195Written as sulindac
- Sulindac and Tamoxifen in Treating Patients With Desmoid TumorCompletedPhase 2Children's Oncology GroupNCT00068419Written as sulindac
- Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of MelanomaCompletedPhase 2National Cancer Institute (NCI)NCT00841204Written as sulindac
- Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and NeckTerminatedPhase 2Massachusetts General HospitalNCT00392665Written as Sulindac
- Sulindac for Patients With AMLWithdrawnPhase 2Massachusetts General HospitalNCT01843179Written as Sulindac
- Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal NeoplasiaCompletedPhase 2National Cancer Institute (NCI)NCT00335504Written as sulindac
- A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedPhase 2University of UtahNCT01187901Written as Sulindac
- Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal CancerTerminatedPhase 2National Cancer Institute (NCI)NCT01856322Written as Sulindac
- Sulindac Capsules Compared With Sulindac Tablets in Healthy VolunteersCompletedNot applicableMayo ClinicNCT00343629Written as sulindac
- A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)WithdrawnPhase 3Cancer Prevention Pharmaceuticals, Inc.NCT01245816Written as Eflornithine plus Sulindac
- Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon PolypsCompletedPhase 3National Cancer Institute (NCI)NCT00118365Written as sulindac
- Sulindac and Epirubicin in Treating Patients With Metastatic Malignant MelanomaCompletedPhase 2Cancer Trials IrelandNCT00755976Written as sulindac
- Urinary Biomarker Study With Sulindac and DifluoromethylornithineWithdrawnPhase 2Cancer Prevention Pharmaceuticals, Inc.NCT01636128Written as Sulindac
- Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial DysplasiaCompletedPhase 2National Cancer Institute (NCI)NCT00368927Written as sulindac
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast CancerCompletedPhase 2Fox Chase Cancer CenterNCT00039520Written as sulindac
Codes
What other systems call Sulindac · ClinicalTrials.gg INT008259
- MeSH (NLM) D013467SulindacConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 184SNS8VUHSULINDACConfirmed FDA, NLM, Wikidata
- RxNorm 10237Confirmed FDA, Wikidata
- Wikidata Q963093sulindacConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C850SulindacOne source FDA
- DrugBank DB00605One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013467 | Sulindac | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 184SNS8VUH | SULINDAC | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10237 | — | Confirmed FDA, Wikidata |
| Wikidata | Q963093 | sulindac | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C850 | Sulindac | One source FDA |
| DrugBank | DB00605 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.